|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2011-5-31
|
|
pubmed:abstractText |
Therapy for chronic hepatitis B reduces the risk of progressing to hepatocellular carcinoma (HCC); however, there is no suitable and accurate means to assess risk. This study aimed to develop and validate a simple scoring system to predict HCC risk in patients with chronic hepatitis B.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1474-5488
|
|
pubmed:author |
pubmed-author:AhnSang-HoonSH,
pubmed-author:ChanHenry Lik-YuenHL,
pubmed-author:ChenChien-JenCJ,
pubmed-author:ChenPei-JerPJ,
pubmed-author:HanKwang-HyubKH,
pubmed-author:KimDo-YoungDY,
pubmed-author:REACH-B Working Group,
pubmed-author:SetoWai-KayWK,
pubmed-author:WongVincent Wai-SunVW,
pubmed-author:YangHwai-IHI,
pubmed-author:YuenMan-FungMF
|
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
568-74
|
|
pubmed:meshHeading |
pubmed-meshheading:21497551-Adult,
pubmed-meshheading:21497551-Aged,
pubmed-meshheading:21497551-Carcinoma, Hepatocellular,
pubmed-meshheading:21497551-Female,
pubmed-meshheading:21497551-Hepatitis B, Chronic,
pubmed-meshheading:21497551-Humans,
pubmed-meshheading:21497551-Liver Neoplasms,
pubmed-meshheading:21497551-Male,
pubmed-meshheading:21497551-Middle Aged,
pubmed-meshheading:21497551-Proportional Hazards Models,
pubmed-meshheading:21497551-ROC Curve,
pubmed-meshheading:21497551-Risk
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score.
|
|
pubmed:affiliation |
Genomics Research Centre, Academia Sinica, Taipei, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
